Effective August 1, 2024, this database was discontinued. All content will remain searchable and be preserved online for historical purposes only until 2029.
Pustular Psoriasis
What's New
Last Posted: Oct 16, 2024
- IL36RN Mutations and Correlated Characteristics in Generalized Pustular Psoriasis Patients in Can Tho City, Vietnam: A Cross-sectional study.
Trang Nguyen Thi Thuy, et al. Dermatology (Basel, Switzerland) 2024 0 1-18 - Comparative Efficacy and Safety of Ustekinumab and Secukinumab in the Treatment of Generalized Pustular Psoriasis: A 48-Week Retrospective Cohort Study with Genetic Background Analysis.
Shi-Fan Ruan, et al. Journal of inflammation research 2024 0 6707-6721 - Rare Filaggrin Variants Are Associated with Pustular Skin Diseases in Asians.
Luca Lo Piccolo, et al. International journal of molecular sciences 2024 0 (12) - Targeted review of IL36RN mutations in patients with generalised pustular psoriasis.
James G Krueger, et al. Skin health and disease 2024 0 (2) e343 - Expression of interleukin-36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene.
Itsumi Mizukawa, et al. The Journal of dermatology 2023 0 - Identification of the BTN3A3 gene as a molecule implicated in generalized pustular psoriasis in a Chinese population.
Zhang Qilin, et al. The Journal of investigative dermatology 2023 0 - Newly revealed variants of SERPINA3 in generalized pustular psoriasis attenuate inhibition of ACT on cathepsin G.
Liu Yaqin, et al. Journal of human genetics 2023 0 - [Genetic Polymorphism of IL36RN in Han Patients with Generalized Pustular Psoriasis Alone in Sichuan Region].
Li Zhong-Tao, et al. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2018 0 (4) 582-586 - Clinical and genetic differences between pustular psoriasis subtypes.
Twelves Sophie, et al. The Journal of allergy and clinical immunology 2018 0 (3) 1021-1026 - Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients.
Xiaoling Yu, et al. Anais brasileiros de dermatologia 2019 0 (6) 658-663 - Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases.
Haskamp Stefan, et al. American journal of human genetics 2020 0 (3) 527-538 - Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center.
Mori Miho, et al. The Journal of dermatology 2021 0 (11) 1745-1753 - Identification of variants in genes associated with autoinflammatory disorders in a cohort of patients with psoriatic arthritis.
Atschekzei Faranaz, et al. RMD open 2022 0 (2) - Elderly-onset generalized pustular psoriasis: a case series.
Chao Jen-Ping, et al. Clinical and experimental dermatology 2022 0 (8) 1567-1570 - Pustular psoriasis of pregnancy: Clinical and genetic characteristics in a series of eight patients and review of the literature.
Ennouri Mariem, et al. Dermatologic therapy 2022 0 (8) e15593 - Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes.
Wang Yirong, et al. Journal of dermatological science 2017 0 (3) 235-240 - Generalized pustular psoriasis (von Zumbusch).
Romiti Ricardo, et al. Anais brasileiros de dermatologia 2021 0 (1) 63-74 - Pustular psoriasis as an autoinflammatory keratinization disease (AiKD): Genetic predisposing factors and promising therapeutic targets.
Akiyama Masashi, et al. Journal of dermatological science 2022 0 (1) 11-17 - Metabolic syndrome-related SNPs in HLA and TNF7L2 may be risk factors for generalized pustular psoriasis in Chinese Han population.
Liu Y, et al. Skin health and disease 2021 6 (2) e18 - Genome-wide association meta-analysis identifies 29 new acne susceptibility loci.
Mitchell Brittany L, et al. Nature communications 2022 0 (1) 702 - Copy Number Variation Analysis of IL22 and LCE3C in Different Subtypes of Psoriasis in a Chinese Han Population.
Zhu Caihong, et al. Medical science monitor : international medical journal of experimental and clinical research 2021 12 e934927 - Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis.
Liu Zhi-Jie, et al. Medicine 2020 11 (45) e23068 - Tumor necrosis factor -238A is associated with pediatric-onset generalized pustular psoriasis in Han patients in Eastern China.
Zhao Lishi, et al. The Journal of dermatology 2019 8 - Polymorphisms in IL36G gene are associated with plaque psoriasis.
Traks Tanel, et al. BMC medical genetics 2019 1 (1) 10 - Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China: A case-control study.
Li Zhongtao, et al. Medicine 2018 8 (31) e11741 - Association of IL36RN mutations with clinical features, therapeutic response to acitretin, and frequency of recurrence in patients with generalized pustular psoriasis.
Zhu Teng, et al. European journal of dermatology : EJD 2018 4 - The genetic basis for most patients with pustular skin disease remains elusive.
Mössner R, et al. The British journal of dermatology 2017 8 - Mutation analysis of IL36RN gene in Japanese patients with palmoplantar pustulosis.
Takahashi Toshifumi, et al. The Journal of dermatology 2016 8 - Tumor Necrosis Factor-alpha Induced Protein 3 Interacting Protein 1 Gene Polymorphisms and Pustular Psoriasis in Chinese Han Population.
Han Jian-Wen, et al. Chinese medical journal 0 0 (13) 1519-1524 - Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status.
Arakawa Akiko, et al. JAMA dermatology 2016 4 - Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients.
Wang Ting-Shun, et al. Archives of dermatological research 2015 11 - HLA-C and TNF gene polymorphisms are associated with psoriasis in Brazilian patients.
Cardili Renata N, et al. International journal of dermatology 2015 10 - Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki Dorottya M, et al. The Journal of investigative dermatology 2015 7 - Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris.
Li Xiuyan, et al. Journal of dermatological science 2014 11 (2) 132-8 - Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients.
Mössner Rotraut, et al. The Journal of investigative dermatology 2015 10 (10) 2538-41 - Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk.
D?bniak T, et al. Archives of dermatological research 2014 4 (3) 231-8 - IL36RN gene mutations are not associated with sporadic generalized pustular psoriasis in Chinese patients.
Li M, et al. The British journal of dermatology 2013 2 (2) 452-5 - Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Jordan Catherine T, et al. American journal of human genetics 2012 5 (5) 796-808 - Generalized pustular psoriasis
From NCATS Genetic and Rare Diseases Information Center - Pustular psoriasis
From NCATS Genetic and Rare Diseases Information Center
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
Browse full list of rare diseases
A-Z
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: